-
2011
Company Description
Esanex is a drug development company that focuses on advancing its highly selective and orally active Hsp90 inhibitors.
Esanex is a drug development company focused on advancing its highly selective, orally active Hsp90 inhibitors. SNX-5422, created from a novel chemical scaffold that is unique in the Hsp90 field, has shown outstanding pre-clinical activity in a number of tumor models and is currently completing Phase 1 trials.
-
Manufacturer:
Information Technology -
Formed:
2011 -
Company Website:
-
Company E-mail:
-
Company Address:
115 W. Washington Street, SUITE 1680 SOUTH TOWERIndianapolis, INUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits